David E I Pyott Alnylam Pharmaceuticals, Inc. (ALNY) insider trading activity

ALNY Quotes by TradingView

David E I Pyott is Director of ALNYLAM PHARMACEUTICALS, INC.. Currently has a direct ownership of 136 shares of ALNY, which is worth approximately $36,722. The most recent transaction as insider was on Mar 24, 2025, when has been sold 7,440 shares (Common Stock) at a price of $299.0 per share, resulting in proceeds of $2,224,560. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 136
0% 3M change
0% 12M change
Total Value Held $36,722

DAVID E I PYOTT Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 24 2025
SELL
Open market or private sale
$2,224,560 $299.0 p/Share
7,440 Reduced 98.2%
136 Common Stock
Mar 24 2025
BUY
Exercise of conversion of derivative security
$661,788 $88.95 p/Share
7,440 Added 49.55%
7,576 Common Stock
Jun 24 2024
SELL
Open market or private sale
$7,171,450 $221.0 p/Share
32,450 Reduced 99.58%
136 Common Stock
Jun 24 2024
BUY
Exercise of conversion of derivative security
$2,500,272 $77.05 p/Share
32,450 Added 49.9%
32,586 Common Stock
Feb 23 2023
BUY
Exercise of conversion of derivative security
-
136 Added 50.0%
136 Common Stock

Also insider at

BMRN
BIOMARIN PHARMACEUTICAL INC Healthcare
Director
PLRX
PLIANT THERAPEUTICS, INC. Healthcare
Director
DEI

David E I Pyott

Director
Cambridge, MA

Track Institutional and Insider Activities on ALNY

Follow ALNYLAM PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALNY shares.

Notify only if

Insider Trading

Get notified when an Alnylam Pharmaceuticals, Inc. insider buys or sells ALNY shares.

Notify only if

News

Receive news related to ALNYLAM PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALNY